Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Mar 27:2020:7834173.
doi: 10.1155/2020/7834173. eCollection 2020.

Extracorporeal Hemadsorption versus Glucocorticoids during Cardiopulmonary Bypass: A Prospective, Randomized, Controlled Trial

Affiliations
Randomized Controlled Trial

Extracorporeal Hemadsorption versus Glucocorticoids during Cardiopulmonary Bypass: A Prospective, Randomized, Controlled Trial

Gordana Taleska Stupica et al. Cardiovasc Ther. .

Abstract

Extracorporeal hemadsorption may reduce inflammatory reaction in cardiopulmonary bypass (CPB) surgery. Glucocorticoids have been used during open-heart surgery for alleviation of systemic inflammation after CPB. We compared intraoperative hemadsorption and methylprednisolone, with usual care, during complex cardiac surgery on CPB, for inflammatory responses, hemodynamics, and perioperative course. Seventy-six patients with prolonged CPB were recruited and randomized, with 60 included in final analysis. Allocation was into three groups: Methylprednisolone (n = 20), Cytosorb (n = 20), and Control group (usual care, n = 20). Proinflammatory (TNF-α, IL-1β, IL-6, and IL-8) and anti-inflammatory (IL-10) cytokines which complement C5a, CD64, and CD163 expression by immune cells were analyzed within the first five postoperative days, in addition to hemodynamic and clinical outcome parameters. Methylprednisolone group, compared to Cytosorb and Control had significantly lower levels of TNF-α (until the end of surgery, p < 0.001), IL-6 (until 48 h after surgery, p < 0.001), and IL-8 (until 24 h after surgery, p < 0.016). CD64 expression on monocytes was the highest in the Cytosorb group and lasted until the 5th postoperative day (p < 0.016). IL-10 concentration (until the end of surgery) and CD163 expression on monocytes (until 48 h after surgery) were the highest in the Methylprednisolone group (p < 0.016, for all measurements between three groups). No differences between groups in the cardiac index or clinical outcome parameters were found. Methylprednisolone more effectively ameliorates inflammatory responses after CPB surgery compared to hemadsorption and usual care. Hemadsorption compared with usual care causes higher prolonged expression of CD64 on monocytes but short lasting expression of CD163 on granulocytes. Hemadsorption with CytoSorb® was safe and well tolerated. This trial is registered with clinicaltrials.gov (NCT02666703).

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this article.

Figures

Figure 1
Figure 1
Flowchart of patients in the randomized trial.
Figure 2
Figure 2
Cytokines and C5a complement.
Figure 3
Figure 3
CD64 and CD163 expression on monocytes, granulocytes, and lymphocytes.
Figure 4
Figure 4
Laboratory secondary outcome measures.
Figure 5
Figure 5
Hemodynamic parameters.
Figure 6
Figure 6
Consumption of noradrenalin (a) and insulin (b).

References

    1. Quaniers J. M., Leruth J., Albert A., Limet R. R., Defraigne J.-O. Comparison of inflammatory responses after off-pump and on-pump coronary surgery using surface modifying additives circuit. The Annals of Thoracic Surgery. 2006;81(5):1683–1690. doi: 10.1016/j.athoracsur.2005.11.059. - DOI - PubMed
    1. Melek F. E., Baroncini L. A. V., Repka J. C. D., Nascimento C. S., PrécomaPrécoma D. B. Oxidative stress and inflammatory response increase during coronary artery bypass grafting with extracorporeal circulation. Revista Brasileira De Cirurgia Cardiovascular. 2012;27(1):61–65. doi: 10.5935/1678-9741.20120010. - DOI - PubMed
    1. Giomarelli P., Scolletta S., Borrelli E., Biagioli B. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. The Annals of Thoracic Surgery. 2003;76(1):117–123. doi: 10.1016/s0003-4975(03)00194-2. - DOI - PubMed
    1. Rubens F. D., Nathan H., Labow R., et al. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass. The Annals of Thoracic Surgery. 2005;79(2):655–665. doi: 10.1016/j.athoracsur.2004.07.044. - DOI - PubMed
    1. Oliver W. C., Nuttall G. A., Orszulak T. A., et al. Hemofiltration but not steroids results in earlier tracheal extubation following cardiopulmonary bypass. Anesthesiology. 2004;101(2):327–339. doi: 10.1097/00000542-200408000-00013. - DOI - PubMed

Publication types

MeSH terms

Associated data